During the past decade, Cleveland Clinic Lerner College of Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Lerner College of Medicine" #1 sponsor was "Chugani, Diane C." with 1 trials, followed by "Clear Creek Bio, Inc." with 1 trials sponsored, "Clinical Evaluation Research Unit at Kingston General Hospital" with 1 trials sponsored, "GTx" with 1 trials sponsored and "International Urogynecological Society" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Lerner College of Medicine" #1 collaborator was "Amarex Clinical Research" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Washington University School of Medicine" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Lerner College of Medicine" are "AVB - Atrioventricular Block" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Acute Respiratory Failure" (1 trials), "Autistic Disorder" (1 trials) and "Bacterial Pneumonia" (1 trials). Many other conditions were trialed in "Cleveland Clinic Lerner College of Medicine" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Lerner College of Medicine" are "Drug" (8 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Brequinar/Brequinar + Ribavirin" (1 trials), "Buspirone" (1 trials), "CYT107" (1 trials) and "Combination product: Trastuzumab + Pertuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Lerner College of Medicine" are 6 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Lerner College of Medicine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cleveland Clinic Lerner College of Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Lerner College of Medicine, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".